Pediatric histiocytosis updates at SPD 2026 reveal BRAF/MEK targets as dermatopathology and biopsy genetics boost accuracy in complex childhood dermatoses.
Mark Koh, MD
Advertisement
Mark Koh, MD, is a pediatric dermatologist and dermatopathologist at KK Women's and Children's Hospital in Singapore.
Articles by Mark Koh, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Sanofi Discontinues Development of OX40L Inhibitor Amlitelimab in Atopic Dermatitis
2
Sunscreen’s New Blind Spot: Fashion Trends, Tanning Myths, and the Rise of Gluteal Melanomas
3
SPD 2026: Clinical Considerations and Inclusive Communication in Pediatric Gender-Affirming Dermatology
4
Tailoring Pediatric Vitiligo Treatment: Insights from SPD 2026
5